Medical Analysis

Understanding Urine Catecholamine Testing: HVA and VMA Diagnostics

By: Dr. Dipak Ladda, M.D.

The measurement of homovanillic acid (HVA) and vanillylmandelic acid (VMA) in urine serves as a vital diagnostic tool. These measurements are primarily utilized to screen pediatric populations for catecholamine-secreting tumors, including neuroblastoma, pheochromocytoma, and other neural crest tumors. Furthermore, this testing is essential for monitoring the efficacy of treatment in patients who have been diagnosed with these conditions.

The Role of Catecholamines in Physiological Stress Response

Catecholamines—comprising epinephrine (adrenaline), norepinephrine, and dopamine—are hormones released by the adrenal glands in response to physical or emotional stress. These hormones prepare the body for intense physical activity, commonly referred to as the “fight-or-flight” response. During this activation, the sympathetic nervous system triggers physiological changes such as increased heart rate, elevated blood pressure, and a surge in blood glucose levels. Once these hormones have performed their function, the body processes and eliminates the remaining waste products through the urine.

Clinical Indications for Estimating Catecholamine Metabolites

Testing is indicated for patients exhibiting symptoms or conditions associated with abnormal catecholamine production. Primary indications include:

• Hypertension

• Excessive sweating

• Severe, persistent headaches

• Suspected neuroblastoma or pheochromocytoma

• Ganglioblastoma and ganglioneuroma

• Adrenal tumors and other neural crest tumors

Diagnostic Procedures and Laboratory Estimation

Urine catecholamine testing is categorized into two main types: random urine testing and 24-hour urine collection. The 24-hour collection method is a standard, precise procedure requiring specific instructions.

Protocols for 24-Hour Urine Collection

To perform a 24-hour collection accurately:

• Add the required preservative (25 mL of 50% acetic acid) to the collection container.

• Instruct the patient to void at 8 AM and discard that initial specimen.

• Collect all subsequent urine, including the final specimen voided at the end of the 24-hour period (e.g., at 8 AM the next morning).

Methods of Estimation

Modern laboratories utilize highly sensitive analytical techniques for this assessment, most notably Liquid Chromatography with tandem mass spectrometry (LC-MS-MS).

Normal Reference Ranges for VMA and HVA

The following table outlines the normal reference ranges for VMA and HVA based on age, expressed in mg/g of creatinine (CRT).

Clinical Significance and Interpretations

Testing is critical for identifying tumors arising from the neural crest, such as pheochromocytoma, neuroblastoma, ganglioneuroma, ganglioneuroblastoma, melanoma, neurofibroma, and schwannoma. Beyond initial identification, these tests are used to evaluate how these tumors respond to various treatment options. Additionally, the test is crucial for investigating the root cause of symptoms like hypertension and excessive sweating linked to catecholamine excess.

Limitations of Testing

The primary limitation of this test is the significant influence of urinary creatinine levels on VMA and HVA measurements. Diluted urine samples containing less than 5 mg/dL of creatinine or strongly concentrated samples exceeding 120 mg/dL are considered unsuitable for accurate measurement when expressed per mg of creatinine.

For Non-Medicos: Understanding Your Urine Test

If your doctor has ordered a test for VMA and HVA, they are looking at how your body handles “stress hormones” called catecholamines. These are natural chemicals like adrenaline that your body releases when you are under stress or preparing for action. Normally, after these hormones are used, your body breaks them down and flushes them out in your urine.

Why is this test done?

Doctors use this test to check for specific, rare types of tumors (like neuroblastoma or pheochromocytoma) that can cause your body to produce way too many of these hormones. By measuring the waste products (VMA and HVA) in your pee, doctors can see if these hormones are being made in dangerous amounts. This test is also a great way to monitor if a patient is responding well to medical treatment.

Key things to remember:

• The 24-hour collection: You will likely be asked to collect your urine for a full 24 hours. It is very important to follow the lab’s instructions exactly—especially about discarding the first morning sample—to ensure the results are correct.

• The preservative: The collection bottle usually contains a preservative to keep the urine stable. Be careful with this bottle and keep it out of reach of children.

• The creatinine factor: The accuracy of this test depends on how concentrated your urine is. The lab checks your creatinine level to make sure the sample is not too watery or too concentrated, which could lead to a wrong result.

References:

• Matthay, K. K., George, R. E., & Yu, A. L. (2012). Promising therapeutic targets in neuroblastoma. Clinical Cancer Research, 18(10), 2740–2753.

• Barco, S., Gennai, I., Reggiardo, G., Galli, L., Barbagallo, L., & Bianchi, M. (2014). Catecholamine-secreting tumors: A review of the diagnostic role of urinary VMA and HVA. Journal of Clinical Laboratory Analysis, 28(5), 415–424.

• Eisenhofer, G., Peitzsch, M., & Pacak, K. (2018). Diagnosis and management of pheochromocytoma and paraganglioma: The role of catecholamine metabolite measurement. Nature Reviews Endocrinology, 14(6), 335–350.

• De Graaf, M. R., & Verhofstad, A. A. (1993). Catecholamine-secreting tumors: Clinical and diagnostic aspects. European Journal of Pediatrics, 152(6), 460–467.

• Tuchman, M., Auray-Blais, C., & Rashed, M. S. (2012). Diagnostic challenges in neuroblastoma: The role of urinary metabolites. Pediatric Blood & Cancer, 59(6), 1010–1014.

• Sawka, A. M., Prebtani, N., Bañares, A., Bajnok, L., & Ezzat, S. (2003). The diagnostic utility of urinary vanillylmandelic acid and homovanillic acid in pheochromocytoma. Endocrine, 22(3), 201–207.

• Armstrong, M. D., McMillan, A., & Shaw, K. N. (1957). 3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine. Biochimica et Biophysica Acta, 25(2), 422–423.

• Pepin, M. G., & Tuchman, M. (2004). Biochemical testing for neuroblastoma. Journal of Pediatric Hematology/Oncology, 26(4), 219–224.

• Pacak, K., Linehan, W. M., Eisenhofer, G., Walther, M. M., & Goldstein, D. S. (2001). Recent advances in the diagnosis and localization of pheochromocytoma. Annals of Internal Medicine, 134(4), 315–329.

• Weinstein, J. L., Cohn, S. L., & Castleberry, R. P. (2003). The International Neuroblastoma Staging System. Journal of Pediatric Hematology/Oncology, 25(11), 867–872.

• Lenders, J. W., Duh, Q. Y., Eisenhofer, G., Gimenez-Roqueplo, A. P., Grebe, S. K., Murad, M. H., … & Young, W. F. (2014). Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 99(6), 1915–1942.

• Verhofstad, A. A., & De Graaf, M. R. (1995). Diagnostic value of urinary catecholamine metabolites in neuroblastoma. Clinical Biochemistry, 28(3), 269–275.

• Peaston, R. T., & Weinkove, C. (2004). Measurement of catecholamines and their metabolites. Annals of Clinical Biochemistry, 41(1), 17–38.

• Brodeur, G. M., & Castleberry, R. P. (1997). Neuroblastoma: Markers, staging, and prognosis. Pediatric Clinics of North America, 44(4), 935–969.

• Goldstein, D. S., Eisenhofer, G., & Pacak, K. (2003). Sympathoadrenal system and stress: The role of catecholamines in the fight-or-flight response. Journal of Physiology, 547(Pt 1), 303–311.

FAQ’s:

• What is VMA and HVA?
  These are urinary waste products measured to screen for catecholamine-secreting tumors like neuroblastoma.

• What are catecholamines?
  Hormones like adrenaline and dopamine released by adrenal glands during stress to trigger physical responses.

• Why perform this test?
  It identifies and monitors neural crest tumors and helps investigate symptoms like hypertension or sweating.

• What conditions are indicated?
  Testing is indicated for neuroblastoma, pheochromocytoma, ganglioneuroma, adrenal tumors, and persistent hypertension or severe headaches.

• How is the sample collected?
  It requires a precise 24-hour urine collection using a container with an acetic acid preservative.

• How to collect 24-hour urine?
  Discard the first morning void at 8 AM, then collect all urine until 8 AM next day.

• How is the test performed?
  Laboratories use highly sensitive Liquid Chromatography with tandem mass spectrometry (LC-MS-MS) for accurate measurement.

• What affects test accuracy?
  Urinary creatinine levels significantly influence results; samples that are too diluted or concentrated are unsuitable.

• Are reference ranges age-dependent?
  Yes, reference ranges for VMA and HVA are stratified based on age groups from infancy to adulthood.

• Is this test diagnostic?
  It is one of the best diagnostic tools for screening and monitoring catecholamine-secreting tumors in children.